Study: Better Diagnostics Don’t Improve Antibiotic Prescription for MRSA

Using rapid molecular diagnostic testing for multidrug-resistant bacteria among patients with purulent skin infections did not reduce inappropriate antibiotic prescription of MRSA antibiotics for patients without an infection caused by the pathogen, according to research in Clinical Infectious Diseases.

Advertisement

The study followed 165 patients, 47 of whom tested positive for MRSA.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Researchers determined from a model that rapid diagnostic testing should have decreased inappropriate MRSA antibiotic prescription from 58 percent to 6.5 percent, though rates only dropped to 45 percent in practice, according to the study.

More Articles on Infection Control & Clinical Quality:

Study: Infection May Speed Cognitive Decline in Older Adults

Daily Chlorhexidine Baths Reduce MRSA Rates in ICU

Standard Cleaning Methods Don’t Kill HPV on Medical Equipment

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.